Sodium 4,5-dihydroxy-3,6-dioxocyclohexa-1,4-diene-1,2-bis(olate), 97.0%, 100g

3-Amino-N-benzyloxycarbonyl-L-alanine>98.0%(HPLC)(T)1g

(4R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol, 98%, 250mg

BENZYL BENZYLCARBAMATE, 95.0%, 5g

7-Fluoro-2,3-dihydro-1H-cyclopenta[b]quinoline-9-carboxylic acid, 97%, 5g

(2-Oxo-pyrrolidin-1-yl)-acetic acid, 95.0%, 5g

Transition piece with sleeve and stop cock, 14/23, 1 Piece

6-Bromo-3-iodo-1H-indazole, 95.0%, 250mg

4-Formyl-5-methyl-1H-pyrrole-2-carboxylic acidethyl ester, 97%, 1g

(R)-3-Amino-1-N-Boc-piperidine, 97.0%, 1g

1-(5-Bromo-7-nitroindolin-1-yl)ethanone, 98.0%, 1g

5-(Chloromethyl)-4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole, 95.0%, 5g

Methyl 5-bromo-2-(dimethylamino)benzoate, 95.0%, 5g